What is Semax? A guide to neuropeptide research

Semax is a synthetic peptide investigated in neurological research, including work involving acute ischemic stroke. Findings in a particular clinical setting do not prove that a separate research product improves focus, sleep or general wellbeing.

What is Semax?

Semax is a synthetic peptide investigated in neurological research, including work involving acute ischemic stroke. Findings in a particular clinical setting do not prove that a separate research product improves focus, sleep or general wellbeing. Researchers use study models to explore biological questions. The model and the exact material tested are essential to interpreting a result.

What does the published research show?

A published clinical investigation examined mechanisms associated with Semax in the acute period of ischemic stroke. The patient population, formulation and study design limit how far its findings can be applied.¹

What the evidence does not show

A neurological study is not evidence that a product improves everyday concentration or performance. The DUSK collection includes Semax separately; it was not part of the founder’s three-compound sleep hypothesis.

Studies of an individual compound cannot establish that combining it with other compounds is effective or safe. Personal observations and wearable sleep data can generate questions, but cannot by themselves show cause and effect.

How this relates to the DUSK collection

The DUSK collection brings together five separately listed research products and the founder’s exploratory questions. Read the Semax research listing for its stated strength and pack choices. Matching-strength analytical documentation is pending; do not assume a study tested the listed batch.